These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 434688)
21. Clinical significance of eosinophilia in the diagnosis of halothane-induced liver injury. Fujiwara M; Watanabe A; Sato Y; Shiota T; Nakatsukasa H; Yamada G; Nagashima H Acta Med Okayama; 1984 Feb; 38(1):35-40. PubMed ID: 6702484 [TBL] [Abstract][Full Text] [Related]
23. Halothane hepatitis as seen by the physician. Reed WD; Williams R Br J Anaesth; 1972 Sep; 44(9):935-40. PubMed ID: 4634876 [No Abstract] [Full Text] [Related]
27. Hepatorenal toxicity from sniffing spot-remover (trichloroethylene). Report of 2 cases. Clearfield HR Am J Dig Dis; 1970 Sep; 15(9):851-6. PubMed ID: 5466688 [No Abstract] [Full Text] [Related]
28. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. Paronetto F; Popper H N Engl J Med; 1970 Aug; 283(6):277-80. PubMed ID: 5448331 [No Abstract] [Full Text] [Related]
31. Halothane hepatitis: a critical review. Carney FM; Van Dyke RA Anesth Analg; 1972; 51(1):135-60. PubMed ID: 4399967 [No Abstract] [Full Text] [Related]
32. [Halothane and the liver. Clinical experience]. Williams R Cah Anesthesiol; 1987 Oct; 35(6 Suppl):15-20. PubMed ID: 3676900 [No Abstract] [Full Text] [Related]
33. Hepatitis after chronic abuse of senna. Beuers U; Spengler U; Pape GR Lancet; 1991 Feb; 337(8737):372-3. PubMed ID: 1671276 [No Abstract] [Full Text] [Related]
34. [A case of fulminant hepatitis due to halothane]. Peralma A; Touron JL Cah Anesthesiol; 1989; 37(4):295-7. PubMed ID: 2790555 [No Abstract] [Full Text] [Related]
35. Indicators of drug abuse--hepatitis. Alexander M NIDA Res Monogr; 1977 Mar; (10):123-9. PubMed ID: 405593 [No Abstract] [Full Text] [Related]
36. Prospective and retrospective searches for liver necrosis following halothane anesthesia. Serum enzyme study and case report. DeBacker LJ; Longnecker DS JAMA; 1966 Jan; 195(3):157-60. PubMed ID: 5951795 [No Abstract] [Full Text] [Related]
37. [Hepatitis caused by halothane. A clinical case]. EnrĂquez J; Such J; Espinos JC; Bigorra S; Unzueta MC; Farre A; Sancho FJ Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):731-4. PubMed ID: 3438542 [No Abstract] [Full Text] [Related]
38. [Diagnostic tests for hypersensitivity to halogen compounds]. Mathieu A; Di Padua D Ann Anesthesiol Fr; 1976; 17(3):295-8. PubMed ID: 1078533 [TBL] [Abstract][Full Text] [Related]
39. Chemical hepatitis associated with occupational exposure to halothane in a research laboratory. Sutherland DE; Smith WA Vet Hum Toxicol; 1992 Oct; 34(5):423-4. PubMed ID: 1455611 [TBL] [Abstract][Full Text] [Related]
40. Halothane and post-halothane exposure hepatitis. Buchanan CC; Cameron RJ; Carpenter RD; Currie J; Spencer HT N Z Med J; 1999 Jan; 112(1080):19-20. PubMed ID: 10073163 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]